Advent Technologies Participates in the EU’s Clean Transition Dialogue on Hydrogen in the presence of EU President Ursula von der Leyen
BOSTON–(BUSINESS WIRE)–Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or the “Company”), an innovation-driven leader... Read more.
Spinal Elements® to Feature the Karma®, An Aging Spine, Metal-Free Fixation Solution, at Upcoming 38th Annual Meeting of the North American Spine Society
Live Surgical Demonstration at NASS Surgical Stadium in the Exhibit Hall Thursday, October 19th at 2:30 pm CARLSBAD, Calif.–(BUSINESS WIRE)–Spinal Elements®,... Read more.
Faeth Therapeutics Announces National Academy of Medicine Recognition for Co-founder Dr. Siddhartha Mukherjee
AUSTIN, Texas–(BUSINESS WIRE)–Faeth Therapeutics, a leader in metabolic oncology research and treatment innovation, proudly announces the induction of... Read more.
CommScope Announces Launch of DOCSIS 4.0 ESD RF Amplifier and Optical Node Platforms with Support of Up To 1.8 GHz
Next-generation outside plant platforms streamline path to 10G HFC networks with modular field upgrades for existing DOCSIS infrastructure HICKORY, N.C.–(BUSINESS... Read more.
The Bancorp, Inc. Sets Third Quarter 2023 Financial Results Release Date and Conference Call
WILMINGTON, Del.–(BUSINESS WIRE)–The Bancorp, Inc. (“Bancorp”) (Nasdaq: TBBK) today announced that it will release its third quarter 2023... Read more.
Citigroup Reports Third Quarter 2023 Results
NEW YORK–(BUSINESS WIRE)–Today Citi reported third quarter 2023 results, which can be found on its website at https://www.citigroup.com/global/investors.... Read more.
Boundless Bio Presents Preclinical Data on the Discovery of its Second ecDNA-Directed Therapeutic Candidate, BBI-825, at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Preclinical findings support the advancement of BBI-825, a novel, orally available, selective inhibitor of ribonucleotide reductase (RNR), as a differentiated treatment... Read more.
Franklin Templeton Closed-End Funds Announce Share Repurchases for the Third Quarter of 2023
NEW YORK–(BUSINESS WIRE)–The following Funds announced today their share repurchase activity during the third quarter of 2023. Ticker Fund Name Share... Read more.
Marti Reports 2023 First Half Results; Investing in Scaling Ride-Hailing
ISTANBUL–(BUSINESS WIRE)–Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye’s... Read more.
Data From Incyte’s Povorcitinib Clinical Program to Be Featured at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA)
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring new data from the company’s... Read more.